No products in the cart.
Retatrutide 5mg + Cagrilintide 5mg 10mg (10 Vials / Kit)
Retatrutide and Cagrilintide combination blend for multi-pathway metabolic and appetite regulation research.
- Purity: ≥99%
Description
This blend combines Retatrutide (5mg), a triple GIP/GLP-1/glucagon agonist, with Cagrilintide (5mg), a long-acting amylin analog, targeting four distinct receptor pathways.
Research into multi-agonist approaches suggests synergistic effects on satiety signaling, energy expenditure, and body composition.
For research use only. Not for human consumption.